Reported about 18 hours ago
CVS Health's stock rose following the company's successful Q4 earnings report, which surpassed analysts' revenue and profit forecasts. This positive performance coincides with the implementation of a strategic turnaround plan aimed at improving competitiveness in the pharmaceutical industry and managing operational costs in its Medicare Advantage segment. New CEO David Joyner's initiatives are also being closely analyzed for their potential to drive long-term growth.
Source: YAHOO